Investment
Features
FeesSafety
Academy
More
Pluang+

Compare LYFT Inc (LYFT) vs Medpace Holdings Inc (MEDP) Price & Performance

Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

LYFT Inc vs Medpace Holdings Inc — how do they compare? LYFT Inc trades at $17.5 (market cap $6.64B), while Medpace Holdings Inc trades at $609.54 (market cap $16.90B). The key difference: Medpace Holdings Inc is far larger — about 2.5× LYFT Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, LYFT Inc nearer its low. Which is the better fit depends on your goals.

LYFTMEDP
Market Cap
$6.64B$16.90B
Sector
IndustrialsTechnology
52-Week High
$24.57$620.59
52-Week Low
$12.65$393.42
Enterprise Value
$6.11B$16.52B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

LYFT Inc

No Aura AI signal available yet.

Medpace Holdings Inc

MEDP trades at $590.67, up 0.97% on the day, near its consensus price target of $599.57. The stock shows bullish momentum with a golden cross formation and strong institutional interest, while recent Q2 2026 earnings beat estimates with EPS of $4.25 versus $3.98 expected. Revenue growth remains robust, projected to rise from $2.53 billion in 2025 to $2.8 billion in 2026, supporting a premium valuation with a P/E of 35.4.

Outlook is positive given earnings consistency and raised 2026 guidance, but risks include high valuation sensitivity and a shareholder lawsuit investigation. The stock offers growth potential from a strong backlog and net book-to-bill ratio of 1.13x, though investors should monitor legal developments and competitive pressures in medical services.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About LYFT Inc

Lyft is the second-largest ride-sharing service provider in the U.S., connecting riders and drivers over the Lyft app. Lyft recently entered the Canadian market in an effort to expand its market outside the U.S. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.

Read more on LYFT

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP